Australia Infant Phototherapy Device Market to Surpass US$ 2.47 Billion by 2033 – Renub Research

Rising Neonatal Jaundice Cases, Advancements in Phototherapy Technology, and Government Support Fuel Market Growth

According to Renub Research, the Australia Infant Phototherapy Device Market is projected to grow from US$ 1.88 billion in 2024 to US$ 2.47 billion by 2033, expanding at a CAGR of 3.1% during the forecast period 2025 to 2033. The market growth is primarily driven by the rising incidence of neonatal jaundice, increasing hospital birth rates, technological advancements in phototherapy devices, and supportive healthcare infrastructure in Australia.

Phototherapy remains the most widely used and effective treatment for neonatal jaundicea common condition in newborns caused by excess bilirubin in the blood. With the governments continued focus on maternal and infant health, along with improvements in healthcare accessibility and neonatal care protocols, the demand for infant phototherapy devices is expected to see a steady rise in the coming years.

Increasing Prevalence of Neonatal Jaundice Drives Demand

Neonatal jaundice affects nearly 60% of full-term and 80% of preterm newborns during their first week of life. In Australia, the number of births continues to rise each year, increasing the base of potential infant jaundice cases that require medical intervention. While most cases are mild and resolve naturally, moderate to severe cases require phototherapy to reduce bilirubin levels and prevent complications such as kernicterus.

The growing awareness among parents and healthcare providers regarding early diagnosis and treatment of hyperbilirubinemia is playing a crucial role in expanding the market for infant phototherapy devices in the country. Moreover, the rise in premature births, often associated with higher rates of jaundice, has further boosted the need for advanced neonatal care solutions.

Technological Advancements Transforming Phototherapy Devices

Manufacturers are focusing on developing more efficient, portable, and cost-effective phototherapy systems that offer better clinical outcomes. Innovations in LED-based phototherapy, which provide higher irradiance, uniform light distribution, lower energy consumption, and longer lifespan compared to conventional fluorescent devices, are revolutionizing neonatal care.

Advanced phototherapy units now offer features such as adjustable wavelength, integrated timers, temperature sensors, and automated monitoring systems. These upgrades ensure better treatment efficiency and safety, reducing hospitalization times and improving newborn outcomes. Portable and home-use phototherapy units are also gaining popularity, especially in remote areas and for post-discharge care.

Strong Healthcare Infrastructure and Government Programs Support Growth

Australia's well-established healthcare infrastructure and government-led initiatives aimed at improving infant and maternal health are significantly contributing to the growth of the phototherapy device market. Public hospitals are equipped with advanced neonatal intensive care units (NICUs), and health authorities promote standardized jaundice screening procedures across all birthing centers.

Programs like Newborn Bloodspot Screening (NBS) and national perinatal data collection contribute to early identification and tracking of neonatal disorders, including jaundice. Additionally, public funding through Medicare and other subsidies helps hospitals and clinics access state-of-the-art medical devices, including infant phototherapy equipment, thereby expanding market adoption.

Hospitals Dominate the End-User Segment, but Home Care Devices on the Rise

Hospitals currently represent the largest share in the Australia infant phototherapy device market, as most jaundice cases requiring treatment are addressed in NICUs and pediatric wards. Large public and private hospitals are continuously upgrading their medical equipment to align with global neonatal care standards.

However, the home care segment is witnessing notable growth. With the development of portable and wearable phototherapy systems, parents can now manage mild jaundice cases at home under medical supervision. This trend not only reduces the burden on hospitals but also offers cost-effective and convenient care for families, especially in rural or underserved regions.

Regional Insights: Urban Centers Lead, Rural Outreach Expands

Major urban areas such as Sydney, Melbourne, and Brisbane account for the majority of phototherapy device usage due to high birth rates, dense hospital networks, and access to specialized neonatal care. However, rural and indigenous communities in remote parts of Australia are receiving increased attention from healthcare policymakers.

Mobile healthcare units, telemedicine platforms, and partnerships with local health authorities are facilitating the deployment of phototherapy solutions in rural areas. The government's commitment to equitable healthcare access is expected to drive the distribution and usage of neonatal devices beyond urban hubs, expanding the total addressable market.

Competitive Landscape and Key Players

The Australia infant phototherapy device market is characterized by the presence of both global and domestic players competing on the basis of technology, pricing, after-sales service, and distribution networks. Major manufacturers such as GE Healthcare, Philips, Atom Medical Corporation, Natus Medical Inc., and Drgerwerk AG are actively introducing advanced devices tailored to the Australian healthcare ecosystem.

These companies are also investing in R&D and strategic partnerships with hospitals and clinics to ensure faster adoption of their solutions. The focus remains on delivering high-intensity, low-heat, and user-friendly devices that comply with Australia's regulatory and safety standards.

Market Challenges: Cost Barriers and Training Gaps

Despite a promising growth trajectory, the infant phototherapy device market in Australia faces certain challenges. The high cost of advanced phototherapy units, especially for smaller hospitals or outpatient clinics, may hinder widespread adoption. Additionally, training and upskilling of nursing staff and pediatricians to handle sophisticated equipment effectively is essential to ensure safe and efficient use.

To counter these issues, manufacturers and health departments are investing in staff training modules, rental models, and maintenance contracts to make equipment ownership more accessible and sustainable for healthcare providers of all sizes.

Future Outlook: Innovation and Integration of Smart Technologies

The future of the Australia infant phototherapy device market lies in integration of smart technologies such as AI-based monitoring, remote diagnostics, and automated treatment adjustments based on bilirubin levels and treatment duration. These next-gen devices will enhance care personalization and accuracy while reducing the manual burden on healthcare professionals.

Furthermore, as digital health platforms grow in Australia, remote management of neonatal careincluding jaundicevia connected devices and cloud-based data tracking could emerge as a new frontier in pediatric health services.

Conclusion: A Bright Future for Neonatal Care in Australia

The Australia Infant Phototherapy Device Market is poised for sustained growth, supported by rising neonatal jaundice cases, healthcare modernization, and increasing awareness about early infant care. With a strong public health framework, robust hospital infrastructure, and ongoing technological innovations, the market is well-positioned to meet the evolving needs of Australias neonatal segment.

Manufacturers and stakeholders who invest in innovation, accessibility, and partnerships will be key players in shaping the future of phototherapy-based neonatal care in the region.

New Publish Report:

• Europe Automotive Robotics Market Global Report Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
• Ice Cream Market Global Report by Products (Sticks/Bars, Cones & Cups, Tubs & Bricks, Others), Category (Dairy Based, Non-Dairy Based), Type (Impulse, Take home, Artisanal), Flavor (Chocolate, Vanilla, Fruit, Others), Distribution Channel (Supermarkets and hypermarkets, Convenience Stores, Specialty Stores, Online Sales Channel), Countries and Company Analysis 2025-2033
• Smartphone Market Global Report Forecast by Operating System (iOS Smartphones, Android Smartphones, and Others) Distribution channel (OEM Stores, Retailers, and E-Commerce), Country and Company Analysis 2025-2033

About the Company

Renub Research is a Market Research and Consulting Company with more than 15 years of experience, especially in international Business-to-Business Research, Surveys, and Consulting. We provide a wide range of business research solutions that help companies make better business decisions. We partner with clients across all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our wide clientele includes key players in Healthcare, Travel & Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemicals, Logistics & Automotive, Consumer Goods & Retail, Building & Construction, and Agriculture. Our core team comprises experienced professionals with graduate, postgraduate, and Ph.D. qualifications in Finance, Marketing, Human Resources, Bio-Technology, Medicine, Information Technology, Environmental Science, and more.

Media Contact

Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)
Email: rajat@renub.com
Website: https://www.renub.com

Explore the detailed report and forecast for the growing Australia Infant Phototherapy Device Market at Renub Research.